Ramon Colomer
Ramon Colomer
Hospital La Princesa, Madrid, Spain
Verified email at seom.org
Cited by
Cited by
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
M Aapro, PA Abrahamsson, JJ Body, RE Coleman, R Colomer, L Costa, ...
Annals of oncology 19 (3), 420-432, 2008
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
R Porta, JM Sanchez-Torres, L Paz-Ares, B Massuti, N Reguart, C Mayo, ...
European Respiratory Journal 37 (3), 624-631, 2011
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
JA Menendez, L Vellon, I Mehmi, BP Oza, S Ropero, R Colomer, R Lupu
Proceedings of the National Academy of Sciences 101 (29), 10715-10720, 2004
International conference on the healthy effect of virgin olive oil
European journal of clinical investigation 35 (7), 421-424, 2005
Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2
R Lupu, R Colomer, G Zugmaier, J Sarup, M Shepard, D Slamon, ...
Science 249 (4976), 1552-1555, 1990
n-3 Fatty acids, cancer and cachexia: a systematic review of the literature
R Colomer, JM Moreno-Nogueira, PP García-Luna, P García-Peris, ...
British Journal of Nutrition 97 (5), 823-831, 2007
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of …
JA Menendez, L Vellon, R Colomer, R Lupu
Annals of oncology 16 (3), 359-371, 2005
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer
R Colomer, S Montero, A Lluch, B Ojeda, A Barnadas, A Casado, ...
Clinical Cancer Research 6 (6), 2356-2362, 2000
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A Vazquez‐Martin, R Colomer, J Brunet, R Lupu, JA Menendez
Cell proliferation 41 (1), 59-85, 2008
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner
S Mañes, E Mira, R Colomer, S Montero, LM Real, C Gómez-Moutón, ...
The Journal of experimental medicine 198 (9), 1381-1389, 2003
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
JA Menendez, A Vazquez-Martin, R Colomer, J Brunet, ...
BMC cancer 7 (1), 80, 2007
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
H Gómez, M Hidalgo, L Casanova, R Colomer, DL Pen, J Otero, ...
Journal of clinical oncology 16 (6), 2065-2069, 1998
Overexpression of c‐erbB‐2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy
E Felip, JM Del Campo, D Rubio, MT Vidal, R Colomer, B Bermejo
Cancer 75 (8), 2147-2152, 1995
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
JA Menendez, M del Mar Barbacid, S Montero, E Sevilla, E Escrich, ...
European journal of cancer 37 (3), 402-413, 2001
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors
JI Mayordomo, F Rivera, MT Diaz-Puente, P Lianes, R Colomer, ...
JNCI: Journal of the National Cancer Institute 87 (11), 803-808, 1995
Mediterranean diet, olive oil and cancer
R Colomer, JA Menéndez
Clinical and Translational Oncology 8 (1), 15-21, 2006
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53 …
JA Menendez, I Mehmi, E Atlas, R Colomer, R Lupu
International journal of oncology 24 (3), 591-608, 2004
Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease
R Colomer, A Ruibal, L Salvador
Cancer 64 (8), 1674-1681, 1989
erb B-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erb B-2 oncogene amplification
R Colomer, R Lupu, SS Bacus, EP Gelmann
British journal of cancer 70 (5), 819-825, 1994
Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer: the NEfERT-T randomized clinical trial
A Awada, R Colomer, K Inoue, I Bondarenko, RA Badwe, G Demetriou, ...
JAMA oncology 2 (12), 1557-1564, 2016
The system can't perform the operation now. Try again later.
Articles 1–20